Capsular contracture, a potential complication following breast augmentation or reconstruction, involves the formation of scar tissue around the implant. This hardening can lead to discomfort, distortion of the breast shape, and in some cases, necessitate further surgical intervention. Strategies to mitigate the risk of this complication are multifaceted and begin with careful patient selection, surgical technique, and postoperative management.
Minimizing the incidence of capsular contracture yields several key advantages. It reduces the likelihood of revision surgery, thereby lowering patient morbidity and healthcare costs. Aesthetically pleasing and naturally feeling results are more consistently achieved, leading to greater patient satisfaction and improved quality of life. Historically, the development of textured implants and modifications to surgical approaches have been driven by the desire to minimize this complication.
This article will examine various preventative measures, including implant selection criteria, surgical pocket placement, the role of acellular dermal matrices, and the importance of postoperative care regimens, all aimed at reducing the probability of adverse capsular formation.
1. Implant surface texture
Implant surface texture plays a significant role in determining the risk of capsular contracture. The surface characteristics influence the host tissue response, specifically the formation and organization of the fibrous capsule that inevitably develops around any foreign body. Smooth-surfaced implants tend to elicit a more organized and circumferential capsule, which, in some cases, can contract, leading to firmness and distortion. Textured implants, conversely, promote a more disorganized and less contractile capsule due to increased tissue ingrowth and adherence. This differential tissue interaction is a key component in understanding strategies to mitigate capsular contracture. For instance, historical data revealed higher rates of contracture with smooth implants compared to early textured designs. This observation prompted further research and development of increasingly sophisticated textured surfaces aimed at optimizing tissue integration and minimizing capsular contraction.
The precise mechanism by which texture influences capsular formation is complex and involves several factors, including macrophage activity, collagen deposition, and the expression of various growth factors. Different types of textured implants, such as microtextured and macrotextured, exhibit distinct tissue interactions and subsequent capsular characteristics. Surgeons must consider these nuances when selecting an implant, weighing the potential benefits of reduced contracture risk against other factors, such as the slightly increased risk of late seroma formation associated with certain macrotextured implants. Furthermore, the choice of texture should be considered alongside other preventative measures, such as pocket placement and postoperative management, as part of a comprehensive strategy.
In summary, implant surface texture is a crucial factor in modulating the tissue response and, consequently, the risk of capsular contracture. While textured implants generally demonstrate a lower incidence of contracture compared to smooth implants, the specific type of texture and the individual patient’s characteristics must be carefully considered. Understanding the interplay between implant surface properties and the host tissue response is essential for informed decision-making and optimizing long-term outcomes. Further research continues to refine our understanding of these complex interactions and guide the development of even safer and more effective implant designs.
2. Submuscular pocket placement
Submuscular pocket placement, a technique involving the placement of breast implants beneath the pectoralis major muscle, is a significant surgical strategy in reducing the incidence of capsular contracture. The enhanced tissue coverage and altered biomechanical environment afforded by this placement contribute to a reduced risk of adverse capsular formation.
-
Reduced Implant Contact with Subcutaneous Tissue
Submuscular placement minimizes direct implant contact with subcutaneous tissue, a region rich in inflammatory cells and potential sources of contamination. The intervening muscle layer acts as a barrier, reducing the inflammatory response triggered by the implant and lessening the stimulus for capsule formation. Clinical studies have demonstrated a correlation between submuscular placement and lower rates of capsular contracture compared to subglandular placement.
-
Improved Vascularity and Tissue Perfusion
The pectoralis major muscle provides a robust blood supply, promoting better tissue perfusion around the implant. Adequate vascularity aids in the resolution of inflammation and promotes healthier tissue remodeling, decreasing the likelihood of dense scar tissue formation. Cases where compromised blood supply exists are associated with increased capsular contracture rates.
-
Reduced Implant Palpability and Rippling
Submuscular placement provides enhanced soft tissue coverage, reducing the palpability of the implant edges and minimizing the appearance of rippling, particularly in patients with thin subcutaneous tissue. The added muscle layer contributes to a more natural contour and improves the overall aesthetic outcome, indirectly contributing to patient satisfaction and reducing the need for revision surgery due to aesthetic concerns related to capsule formation.
-
Dynamic Compression and Reduced Biofilm Formation
The dynamic compression provided by the pectoralis muscle with arm movement may disrupt early biofilm formation on the implant surface. Biofilm, a community of microorganisms encased in a matrix, can trigger chronic inflammation and contribute to capsular contracture. This mechanical disruption may contribute to a lower incidence of infection-related capsular contracture.
Collectively, these facets highlight the multifaceted benefits of submuscular pocket placement in mitigating the risk of capsular contracture. The enhanced tissue coverage, improved vascularity, reduced implant palpability, and potential for biofilm disruption contribute to a more favorable tissue response and a decreased probability of adverse capsular formation. Surgical technique and patient-specific factors must still be considered, as submuscular placement alone does not guarantee complete protection against this complication.
3. Acellular dermal matrix
Acellular dermal matrix (ADM) represents a significant advancement in reconstructive and aesthetic breast surgery, with applications extending to the mitigation of capsular contracture. Derived from human or animal skin, ADM undergoes a process to remove cellular components while preserving the structural collagen matrix. This scaffold can then be utilized to reinforce soft tissue coverage, modulate the inflammatory response, and ultimately decrease the potential for adverse capsular formation around breast implants. The use of ADM fundamentally alters the tissue-implant interface. Instead of direct implant contact with subcutaneous fat, the implant is positioned against the ADM, which integrates with surrounding tissue. This integration promotes neovascularization and improved tissue perfusion, factors known to reduce scar tissue contracture.
The employment of ADM in breast reconstruction, particularly in implant-based procedures following mastectomy, exemplifies its clinical utility. By providing additional soft tissue support, ADM allows for greater control over implant positioning and shape, while simultaneously minimizing the risk of capsular contracture. In cases where prior radiation therapy has compromised tissue quality, ADM is often crucial for creating a suitable implant pocket and reducing the likelihood of complications. Furthermore, ADM’s influence on the inflammatory cascade is considered a key mechanism in its preventative role. By promoting a more balanced inflammatory response, ADM helps to regulate collagen deposition and prevent the formation of a thick, constricting capsule. This is particularly relevant in patients predisposed to exaggerated scarring or those with a history of capsular contracture.
In conclusion, ADM serves as a valuable tool in the armamentarium for minimizing capsular contracture. Its ability to augment soft tissue support, modulate the inflammatory response, and promote favorable tissue integration makes it an important adjunct in breast reconstruction and augmentation procedures. While ADM does not eliminate the risk of capsular contracture entirely, its judicious use contributes to improved aesthetic outcomes and reduced rates of this common complication. Further research continues to explore the optimal applications and long-term benefits of ADM in the context of breast implant surgery.
4. Antibiotic irrigation
Antibiotic irrigation during breast augmentation or reconstruction plays a crucial role in minimizing the risk of capsular contracture. This practice involves the introduction of an antibiotic solution into the surgical pocket prior to implant insertion, aiming to reduce the bacterial load and prevent subsequent biofilm formation. Biofilm, a community of microorganisms adhering to a surface and encased in a self-produced matrix, is increasingly recognized as a significant contributor to chronic inflammation and, consequently, capsular contracture. By reducing the initial bacterial contamination, antibiotic irrigation disrupts the formation of biofilm, thereby mitigating the inflammatory cascade that leads to scar tissue contracture. Studies have demonstrated that the implementation of antibiotic irrigation protocols is associated with a statistically significant decrease in the incidence of capsular contracture. In essence, antibiotic irrigation acts as a preventative measure against subclinical infection, a key driver of adverse capsular formation.
The effectiveness of antibiotic irrigation is contingent upon several factors, including the choice of antibiotic, its concentration, and the duration of exposure within the surgical pocket. Commonly used antibiotics include vancomycin, cefazolin, and gentamicin, selected for their broad spectrum of activity and ability to eradicate common skin flora. The specific antibiotic regimen and concentration should be determined based on institutional protocols and local resistance patterns. For example, some surgeons advocate for a triple antibiotic irrigation solution to maximize the coverage against potential pathogens. Moreover, meticulous surgical technique is essential to prevent the introduction of bacteria during the procedure, maximizing the efficacy of the antibiotic irrigation. Proper skin preparation, sterile draping, and the use of surgical barriers are critical components of infection control.
In conclusion, antibiotic irrigation represents a valuable tool in the prevention of capsular contracture following breast implant surgery. By reducing bacterial contamination and inhibiting biofilm formation, this practice minimizes the inflammatory stimulus that drives adverse scar tissue formation. The selection of appropriate antibiotics, adherence to sterile surgical techniques, and the implementation of comprehensive infection control protocols are all essential for maximizing the benefits of antibiotic irrigation and minimizing the risk of this common complication.
5. Minimized biofilm formation
Biofilm formation on breast implant surfaces is increasingly recognized as a significant etiological factor in capsular contracture. This complex microbial community, encased in a self-produced polymeric matrix, fosters chronic inflammation and immune activation around the implant. The persistent, low-grade inflammatory response, in turn, stimulates fibroblast activity and excessive collagen deposition, ultimately leading to the formation of a dense, constricting capsule. Therefore, strategies aimed at minimizing biofilm formation are integral to preventing capsular contracture. For instance, the use of antibiotic irrigation, as detailed previously, reduces the initial bacterial load, limiting the opportunity for biofilm development. Similarly, meticulous surgical technique, minimizing tissue trauma and potential sources of contamination, directly contributes to a reduced risk of biofilm-mediated inflammation and subsequent contracture.
Practical applications of this understanding are multifaceted. Implementing strict sterile protocols in the operating room, including thorough skin preparation and the use of implant “no-touch” techniques, minimizes bacterial inoculation during surgery. The choice of implant material itself can also influence biofilm formation; certain surface textures and biomaterials may be more resistant to microbial adhesion. Furthermore, post-operative management plays a critical role. While the evidence is still evolving, some surgeons advocate for prophylactic antibiotic use in specific patient populations to further suppress bacterial growth. Additionally, educating patients on proper hygiene and wound care contributes to minimizing the risk of infection and subsequent biofilm formation.
In summary, minimized biofilm formation is a critical component of any comprehensive strategy to avoid capsular contracture. By addressing bacterial contamination at various stages preoperatively, intraoperatively, and postoperatively surgeons can significantly reduce the risk of chronic inflammation and subsequent scar tissue formation. While completely eliminating biofilm formation may be challenging, employing a multi-pronged approach, encompassing surgical technique, antibiotic prophylaxis, and implant material selection, represents a significant advancement in improving long-term outcomes and minimizing the incidence of this common complication. The challenge lies in continuing research to identify the most effective strategies and tailoring them to individual patient needs and risk factors.
6. Postoperative massage
Postoperative massage following breast augmentation or reconstruction is often recommended as a strategy to mitigate the risk of capsular contracture. While the precise mechanisms are not fully elucidated, the practice is believed to influence tissue remodeling and organization around the implant, thereby affecting the final capsular characteristics.
-
Disruption of Early Fibrous Organization
Manual manipulation of the tissues surrounding the implant during the early postoperative period may disrupt the nascent organization of the fibrous capsule. This disruption can prevent the collagen fibers from aligning in a tight, circumferential manner, which is characteristic of a contracting capsule. Regular massage aims to promote a more random and less organized collagen deposition, reducing the potential for firmness and distortion.
-
Improved Tissue Perfusion and Reduced Edema
Massage can enhance blood flow and lymphatic drainage in the surgical area. Increased tissue perfusion promotes the delivery of nutrients and the removal of waste products, facilitating healthier tissue remodeling. Reduced edema minimizes tissue tension and inflammation, contributing to a more favorable environment for capsule formation. Cases where edema persists are more prone to inflammation.
-
Mechanical Modulation of Fibroblast Activity
Fibroblasts, the cells responsible for collagen synthesis, are sensitive to mechanical stimuli. Massage may modulate fibroblast activity, influencing the type and amount of collagen produced. It is hypothesized that controlled mechanical stimulation can encourage the production of more flexible and less contractile collagen, reducing the risk of capsular contracture.
-
Early Detection of Capsular Changes
Consistent self-examination and massage allows the patient to monitor changes in the tissues surrounding the implant more closely. Early detection of firmness or unusual changes can prompt timely intervention, such as adjustments to the massage technique or further medical evaluation, potentially preventing the progression to more severe capsular contracture.
In conclusion, postoperative massage is considered a component of a multifaceted approach to minimize capsular contracture. By influencing tissue organization, improving perfusion, modulating fibroblast activity, and enabling early detection of changes, regular massage contributes to a more favorable tissue-implant interaction. The specific massage technique, frequency, and duration should be guided by the surgeon’s recommendations and tailored to the individual patient’s needs.
7. Steroid use
Steroid use, specifically the localized administration of corticosteroids, is a strategy employed to reduce the risk of capsular contracture following breast augmentation or reconstruction. The rationale behind this approach centers on the anti-inflammatory properties of corticosteroids, which can modulate the wound-healing process and potentially inhibit excessive scar tissue formation. By suppressing the inflammatory cascade that drives fibroblast activation and collagen deposition, steroid use can help to maintain a softer, more pliable capsule around the implant. While not a universal practice, some surgeons advocate for the injection of corticosteroids into the implant pocket during surgery or shortly thereafter, particularly in patients deemed at higher risk for capsular contracture based on factors such as previous contracture or a history of keloid formation. This targeted delivery minimizes systemic exposure to steroids while maximizing the local anti-inflammatory effect.
The mechanism by which steroids influence capsular formation involves multiple pathways. Corticosteroids bind to glucocorticoid receptors on various cell types, including fibroblasts and inflammatory cells. This interaction leads to decreased production of inflammatory mediators, such as cytokines and growth factors, which normally stimulate collagen synthesis. Furthermore, steroids can inhibit the differentiation of fibroblasts into myofibroblasts, cells that exhibit contractile properties and contribute to capsule tightening. The timing and dosage of steroid administration are critical factors to consider. Overly aggressive or prolonged steroid use can potentially impair wound healing and increase the risk of infection, while insufficient doses may not effectively suppress the inflammatory response. Therefore, careful patient selection and adherence to established protocols are essential. Some surgeons have reported success with triamcinolone injected into the implant pocket at the time of surgery, however, this is not a universally accepted practice, with the risks of complications needing careful consideration.
In conclusion, steroid use represents a potential adjunct in the prevention of capsular contracture. By modulating the inflammatory response and influencing fibroblast activity, localized corticosteroid administration can contribute to a softer, more compliant capsule around the breast implant. However, the decision to utilize steroids should be based on a thorough assessment of the individual patient’s risk factors and a careful consideration of the potential benefits and risks. The role of steroids is a complex one, and it doesn’t replace meticulous surgical technique and postoperative management.
8. Careful hemostasis
Meticulous hemostasis during breast augmentation and reconstructive procedures is paramount in minimizing the risk of capsular contracture. Uncontrolled bleeding within the surgical pocket can initiate a cascade of events that promote inflammation and subsequent scar tissue formation, ultimately contributing to capsular contracture. Therefore, achieving thorough hemostasis is an essential aspect of surgical technique aimed at preventing this complication.
-
Reduced Hematoma Formation
Effective hemostasis minimizes the formation of hematomas within the implant pocket. Hematomas act as a nidus for infection and perpetuate a prolonged inflammatory response. The breakdown of blood products releases iron and other compounds that further exacerbate inflammation and stimulate fibroblast activity. By preventing hematoma formation, careful hemostasis reduces the inflammatory stimulus and the subsequent risk of capsular contracture. Postoperative hematoma evacuation is sometimes necessary, if hemostasis intraoperatively was not sufficient, and bleeding occured post operatively, causing discomfort.
-
Decreased Inflammatory Response
Persistent bleeding and clot formation trigger a chronic inflammatory response in the surrounding tissues. This inflammatory response stimulates the proliferation of fibroblasts and the deposition of collagen, leading to the formation of a thick, constricting capsule around the implant. Careful hemostasis limits the inflammatory stimulus, allowing for a more controlled and less aggressive wound-healing process, thereby decreasing the likelihood of capsular contracture. In cases with excessive inflammation, capsule formation is expected to be more severe, and the likeliness of a capsular contracture to occur rises.
-
Minimized Risk of Infection
Hematomas provide a favorable environment for bacterial growth and can significantly increase the risk of surgical site infection. Infection, even subclinical infection, is a known risk factor for capsular contracture. Careful hemostasis reduces the risk of hematoma formation and, consequently, minimizes the risk of infection. A reduced bacterial load promotes a more balanced wound-healing response and decreases the chance of adverse capsular formation. Prevention is the key, so that in case there is a hematoma, surgical site infection will not take place after.
-
Improved Tissue Perfusion
Uncontrolled bleeding can compromise the microcirculation within the implant pocket, leading to tissue ischemia and impaired wound healing. Careful hemostasis preserves tissue perfusion, ensuring adequate oxygen and nutrient delivery to the healing tissues. Improved perfusion promotes healthier tissue remodeling and decreases the likelihood of dense scar tissue formation, thereby reducing the risk of capsular contracture. Tissue perfusion is related with healthy tissue response to the foreign body, and if it is impaired, capsular contracture can take place.
In conclusion, meticulous hemostasis is a critical element in minimizing the risk of capsular contracture. By preventing hematoma formation, decreasing the inflammatory response, minimizing the risk of infection, and improving tissue perfusion, careful hemostasis contributes to a more favorable wound-healing environment and a reduced probability of adverse capsular formation. The implementation of careful hemostatic techniques helps ensure optimal aesthetic outcomes and long-term implant stability.
9. Incision placement
Incision placement in breast augmentation or reconstruction procedures holds a complex relationship with the potential for capsular contracture. Incisions, regardless of their location, disrupt tissue planes and initiate the wound-healing cascade, a process inherently linked to scar tissue formation. The choice of incision site can influence several factors, including the degree of tissue trauma, the risk of bacterial contamination, and the ultimate location of the resulting scar relative to the implant. These factors, in turn, can impact the likelihood of adverse capsular formation. Axillary incisions, for example, while aesthetically appealing due to their concealed location, may present a greater risk of bacterial contamination due to the proximity of sweat glands and hair follicles. This increased risk of infection can stimulate chronic inflammation and subsequent capsular contracture. Inframammary incisions, conversely, offer direct access to the implant pocket and allow for meticulous surgical technique, potentially minimizing tissue trauma. However, the resultant scar is located directly on the breast and may be more susceptible to external pressure or irritation, factors that could also influence capsular formation.
The periareolar incision represents another common approach, offering a balance between aesthetic considerations and surgical access. However, this incision type disrupts the lactiferous ducts and glandular tissue, potentially increasing the risk of inflammation and altering the local tissue environment. The resulting scar, located at the areolar border, can also be prone to hypertrophic scarring in some individuals. The surgeon must consider these factors when selecting an incision site, weighing the potential benefits of each approach against the potential risks. For example, in patients with a history of hypertrophic scarring, an inframammary incision may be preferred to avoid placing the scar in a more conspicuous and potentially problematic location on the breast. The choice of incision placement should also be considered in conjunction with other preventative measures, such as antibiotic irrigation and careful hemostasis, as part of a comprehensive strategy to minimize capsular contracture. Some Surgeons prefere a Transareolar incision, in the areola trought the nipple and after the pectorialis muscle, or even partial submuscular pocket. The choice is determined during evaluation for the patient and anatomy.
In conclusion, incision placement plays a significant, though indirect, role in the prevention of capsular contracture. The choice of incision site influences the degree of tissue trauma, the risk of bacterial contamination, and the location of the resultant scar, all of which can impact the inflammatory response and subsequent scar tissue formation around the implant. The optimal incision placement should be carefully considered in conjunction with other surgical and patient-specific factors, as part of a comprehensive approach to minimizing the risk of this common complication. Further research is ongoing to refine our understanding of the complex interplay between incision placement and capsular formation.
Frequently Asked Questions
This section addresses common inquiries regarding strategies to minimize the risk of capsular contracture following breast augmentation or reconstruction. The information provided aims to offer a comprehensive understanding of preventative measures and their underlying rationale.
Question 1: Is there a guaranteed method to prevent capsular contracture?
No single method guarantees complete prevention. Capsular contracture is a multifactorial process, and while various strategies can significantly reduce the risk, individual patient responses and other unpredictable variables may influence the outcome. A comprehensive approach, incorporating meticulous surgical technique, appropriate implant selection, and postoperative management, offers the best chance of minimizing this complication.
Question 2: Does implant type influence the likelihood of capsular contracture?
Yes, implant surface texture is a significant factor. Textured implants generally exhibit lower rates of capsular contracture compared to smooth implants. The textured surface promotes greater tissue adhesion and a less organized capsule formation, reducing the risk of contracture. However, the specific type of texture and the individual patient’s characteristics must be considered.
Question 3: What is the role of pocket placement in preventing capsular contracture?
Pocket placement significantly influences the risk. Submuscular placement, where the implant is positioned beneath the pectoralis major muscle, provides greater tissue coverage and reduces direct implant contact with subcutaneous tissue. This technique often leads to lower capsular contracture rates compared to subglandular placement.
Question 4: How important is postoperative massage?
Postoperative massage is often recommended to disrupt early fibrous organization and promote better tissue remodeling. Regular massage may prevent the collagen fibers from aligning in a tight, circumferential manner, which is characteristic of a contracting capsule. The specific massage technique and frequency should be guided by the surgeon’s recommendations.
Question 5: Is antibiotic irrigation truly effective?
Antibiotic irrigation of the surgical pocket prior to implant insertion is an effective means of reducing bacterial load and preventing biofilm formation. Biofilm is increasingly recognized as a significant contributor to chronic inflammation and capsular contracture. By minimizing bacterial contamination, antibiotic irrigation helps to disrupt the inflammatory cascade.
Question 6: Can acellular dermal matrix (ADM) prevent capsular contracture?
Acellular dermal matrix (ADM) can be employed to reinforce soft tissue coverage and modulate the inflammatory response. By providing additional support and promoting favorable tissue integration, ADM may reduce the likelihood of adverse capsular formation, particularly in reconstructive procedures following mastectomy.
In summary, effectively mitigating capsular contracture requires a multifaceted approach that addresses implant-related factors, surgical technique, and postoperative management. The strategies outlined above represent evidence-based practices aimed at reducing the incidence of this common complication.
This article will now delve into potential treatment options for established capsular contracture.
Guidance to Reduce Capsular Contracture Risk
The following recommendations offer practical guidance, distilled from current understanding, regarding approaches to minimize the potential for capsular contracture after breast augmentation or reconstruction.
Tip 1: Optimize Implant Selection. Implant surface texture influences tissue response. Textured implants often correlate with lower contracture rates compared to smooth-surfaced options. Consider patient-specific factors such as tissue thickness and aesthetic goals when selecting implant characteristics.
Tip 2: Employ Submuscular Pocket Placement. Submuscular placement positions the implant beneath the pectoralis major muscle, promoting increased tissue coverage and potentially reducing the risk of adverse capsular formation. This technique is particularly beneficial for individuals with limited soft tissue coverage.
Tip 3: Integrate Acellular Dermal Matrix (ADM) When Appropriate. ADM provides additional soft tissue support, particularly in reconstructive cases. This adjunct reinforces the implant pocket and modulates the inflammatory response, potentially mitigating contracture risk in select patients.
Tip 4: Utilize Antibiotic Irrigation. Antibiotic irrigation of the surgical pocket prior to implant insertion minimizes bacterial contamination. This reduces the potential for biofilm formation, a recognized factor in chronic inflammation and subsequent capsular contracture.
Tip 5: Emphasize Meticulous Hemostasis. Thorough hemostasis during the surgical procedure minimizes the risk of hematoma formation. Hematomas trigger inflammatory cascades that can contribute to capsular contracture. Careful attention to hemostasis is crucial.
Tip 6: Consider the Benefit of Postoperative Massage. Implementation of a massage protocol, as advised by the surgeon, can disrupt the early organization of fibrous tissue and promote improved tissue perfusion. Massage protocols can alter capsule formation favorably.
Tip 7: Incision Location to be Mindful Of. The location of the surgical incision can influence the risk of infection and tissue trauma. Select an incision site that balances aesthetic considerations with optimal surgical access and minimizes the potential for contamination.
These measures, implemented diligently, contribute to a decreased likelihood of capsular contracture. Each recommendation addresses specific facets of the surgical procedure and postoperative care, promoting a more favorable tissue-implant interaction.
The concluding section will present insights into the management of established capsular contracture.
Conclusion
This article has presented a comprehensive overview of how to avoid capsular contracture following breast augmentation or reconstruction. Strategies encompass implant selection based on surface texture, surgical techniques such as submuscular pocket placement and meticulous hemostasis, the adjunctive use of acellular dermal matrix, and preventative measures including antibiotic irrigation and postoperative massage. Each approach aims to modulate the inflammatory response, minimize bacterial contamination, and promote optimal tissue integration.
While no single method guarantees complete prevention, adherence to these principles can substantially reduce the incidence of capsular contracture and improve long-term patient outcomes. Continued research and refinement of surgical techniques remain essential to further minimize this complication and enhance the quality of care for individuals undergoing breast implant surgery.
